| 淡江大學 |
2025-12-08 |
Effectiveness and application of blocked and random practice in motor skill learning among special needs populations
|
Huang, C. S.;Wu, C. E.;Lin, T. W.;Chiu, Y. S. |
| 淡江大學 |
2025-12-08 |
Effectiveness and application of blocked and random practice in motor skill learning among special needs populations
|
Huang, C. S.;Wu, C. E.;Lin, T. W.;Chiu, Y. S. |
| 淡江大學 |
2025-12-08 |
The Application of Self-Talk in Enhancing Throwing Performance: The Moderating Role of Player Position in Baseball
|
Lin, T. W.;Chiu, Y. S.;Huang, C. S.;Wu, C. E. |
| 淡江大學 |
2025-12-08 |
Integrating self-talk and wearable technology to enhance motivation, self-efficacy, and muscle function in older adults: A randomized controlled trial.
|
Wu, C. E.;Huang, C. S.;Lin, T. W.;Chiu, Y. S. |
| 淡江大學 |
2025-12-08 |
Effectiveness and application of blocked and random practice in motor skill learning among special needs populations.
|
Huang, C. S.;Wu, C. E.;Lin, T. W.;Chiu, Y. S. |
| 淡江大學 |
2025-12-08 |
The Application of Self-Talk in Enhancing Throwing Performance: The Moderating Role of Player Position in Baseball
|
Lin, T. W.;Chiu, Y. S.;Huang, C. S.;Wu, C. E. |
| 淡江大學 |
2025-12-08 |
The Application of Self-Talk in Enhancing Throwing Performance: The Moderating Role of Player Position in Baseball
|
Lin, T. W.;Chiu, Y. S.;Huang, C. S.;Wu, C. E. |
| 淡江大學 |
2024-08-23T04:05:35Z |
Effects of perception training on aiming stability: An ecological approach
|
Huang, C. S.;Yang, C. M.;Shih, C. C.;Hung, J. H. |
| 淡江大學 |
2024-08-23T04:05:28Z |
Dimensions of geometric object and information patterns in aperture-passing-through task
|
Huang, C. S.;Yang, C. M. |
| 淡江大學 |
2024-08-23T04:05:27Z |
The interception of deceptive short-passing in football.
|
Huang, C. S.;Yang, C. M. |
| 淡江大學 |
2024-08-23T04:05:25Z |
Transfer of calibration between upper and lower limbs' length perception
|
Huang, C. S.;Yang, C. M. |
| 淡江大學 |
2024-08-23T04:05:21Z |
Using the SPLISS framework to explore the development of parasport
|
Huang, C. S.;Pan, C. C.;Hsu, C. Y. |
| 國立成功大學 |
2023 |
Parameter correlation study on two new analytical solutions for radially divergent tracer tests in two-zone confined aquifers with vertical dispersion effect
|
Wang, C.;Huang, C.-S.;Tong, C.;Lee, C.-H. |
| 國立成功大學 |
2023 |
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
|
Hurvitz, S.A.;Hegg, R.;Chung, W.-P.;Im, S.-A.;Jacot, W.;Ganju, V.;Chiu, J.W.Y.;Xu, B.;Hamilton, E.;Madhusudan, S.;Iwata, H.;Altintas, S.;Henning, J.-W.;Curigliano, G.;Perez-Garcia, J.M.;Kim, S.-B.;Petry, V.;Huang, C.-S.;Li, W.;Frenel, J.-S.;Antolin, S.;Yeo, W.;Bianchini, G.;Loi, S.;Tsurutani, J.;Egorov, A.;Liu, Y.;Cathcart, J.;Ashfaque, S.;Cort�s, J. |
| 國立成功大學 |
2023 |
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)
|
Kuo, S.-H.;Tseng, L.-M.;Chen, S.-T.;Sagara, Y.;Chang, Y.-C.;Yeh, H.-T.;Kuo, Y.-L.;Hung, C.-C.;Lu, T.-P.;Lee, Y.-H.;Toi, M.;Huang, C.-S. |
| 國立成功大學 |
2023 |
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-na�ve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
|
Chang, T.-S.;Huang, C.-F.;Kuo, H.-T.;Lo, C.-C.;Huang, C.-W.;Chong, L.-W.;Cheng, P.-N.;Yeh, M.-L.;Peng, C.-Y.;Cheng, Cheng C.-Y.;Huang, J.-F.;Bair, M.-J.;Lin, C.-L.;Yang, C.-C.;Wang, S.-J.;Hsieh, T.-Y.;Lee, T.-H.;Lee, P.-L.;Wu, Wu W.-C.;Lin, C.-L.;Su, W.-W.;Yang, S.-S.;Wang, C.-C.;Hu, J.-T.;Mo, L.-R.;Chen, Chen C.-T.;Huang, Y.-H.;Chang, Chang C.-C.;Huang, C.-S.;Chen, G.-Y.;Kao, C.-N.;Tai, C.-M.;Liu, C.-J.;Lee, M.-H.;Tsai, P.-C.;Dai, C.-Y.;Kao, J.-H.;Lin, H.-C.;Chuang, W.-L.;Chen, Chen C.-Y.;Tseng, K.-C.;Hung, C.-H.;Yu, M.-L. |
| 臺大學術典藏 |
2022-09-20T06:48:26Z |
Artificial Intelligence Aids Cardiac Image Quality Assessment for Improving Precision in Strain Measurements
|
Huang K.-C.; Huang C.-S.; Su M.-Y.; Hung C.-L.; Ethan Tu Y.-C.; Lin L.-C.; HWANG, JUEY-JEN |
| 臺大學術典藏 |
2022-09-15T01:09:55Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Chia-Chi Lin; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2022-09-09T04:21:34Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:31Z |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang C.-F.; Kuo H.-T.; Chang T.-S.; Lo C.-C.; Hung C.-H.; Huang C.-W.; Chong L.-W.; Cheng P.-N.; Yeh M.-L.; Peng C.-Y.; Cheng C.-Y.; Huang J.-F.; Bair M.-J.; Lin C.-L.; Yang C.-C.; Wang S.-J.; Hsieh T.-Y.; Lee T.-H.; Lee P.-L.; Wu W.-C.; Su W.-W.; Yang S.-S.; Wang C.-C.; Hu J.-T.; Mo L.-R.; Chen C.-T.; Huang Y.-H.; Chang C.-C.; Huang C.-S.; Chen G.-Y.; Kao C.-N.; Tai C.-M.; Liu C.-J.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; JIA-HORNG KAO; Lin H.-C.; Chuang W.-L.; Chen C.-Y.; Tseng K.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:25Z |
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
|
Chen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:21Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; Hsu S.-J.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:18Z |
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan
|
Lo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
|
Dai M.-S.; Liu L.-C.; Wang M.-Y.; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO; Huang C.-S.; Yeh D.-C.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Lin P.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.; Chang K.-J.; Chen M.M.; Lu Y.-S.; Bu C.-F.; CHIUN HSU; Huang C.-S.; Chao T.-Y. |
| 臺大學術典藏 |
2022-08-19T00:21:10Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; CHIUN HSU; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:02Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C. |
| 臺大學術典藏 |
2022-08-19T00:20:59Z |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
Lu Y.S.; Cheng A.L.; Kuo W.H.; Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:20:54Z |
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
|
Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; CHIUN HSU; Lin M.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-08-12T06:29:13Z |
HER-2/neu overexpression in Chinese breast cancers: correlation with other prognostic factors.
|
Huang C.S.; Chen Y.C.; Wang M.; Lin J.K.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:29:13Z |
Breast cancer vascularity: Color Doppler sonography and histopathology study
|
Lee W.-J.; Chu J.-S.; Huang C.-S.; Chang M.-F.; KING-JEN CHANG; Chen K.-M. |
| 臺大學術典藏 |
2022-08-12T06:29:13Z |
Photodynamic effect on breast and colon cancer cells of use of merocyanine 540 as a photosensitizer
|
Huang C.-S.; Huang S.-H.; Lin T.-I.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:29:10Z |
Ages at different reproductive events, numbers of menstrual cycles in between and breast cancer risk
|
Chie W.-C.; Fu C.-M.; Lee W.-C.; Li C.-Y.; Huang C.-S.; KING-JEN CHANG; Lin R.-S. |
| 臺大學術典藏 |
2022-08-12T06:29:06Z |
Body size as a factor in different ages and breast cancer risk in Taiwan
|
Chie W.-C.; Li C.-Y.; Huang C.-S.; KING-JEN CHANG; Lin R.-S. |
| 臺大學術典藏 |
2022-08-12T06:29:05Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Chie W.-C.; Li C.-Y.; Huang C.-S.; KING-JEN CHANG; Yen M.-L.; Lin R.-S. |
| 臺大學術典藏 |
2022-08-12T06:29:03Z |
Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan
|
Chu J.-S.; Huang C.-S.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:29:02Z |
The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast carcinomas
|
Chu J.-S.; Huang C.-S.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:29:01Z |
Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset)
|
Lo Y.-L.; Yu J.-C.; Huang C.-S.; Tseng S.-L.; Chang T.-M.; KING-JEN CHANG; Wu C.-W.; Shen C.-Y. |
| 臺大學術典藏 |
2022-08-12T06:28:59Z |
Microcalcifications of non-palpable breast lesions detected by ultrasonography: Correlation with mammography and histopathology
|
Huang C.-S.; Wu C.-Y.; Chu J.-S.; Lin J.-H.; Hsu S.-M.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:28:58Z |
Measurement of the quality of life during different clinical phases of breast cancer
|
Chie W.-C.; Huang C.-S.; Chen J.-H.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:28:57Z |
p27 expression as a prognostic factor of breast cancer in Taiwan
|
Chu J.-S.; Huang C.-S.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:28:56Z |
Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan
|
Huang C.-S.; Shen C.-Y.; KING-JEN CHANG; Hsu S.-M.; Chern H.-D. |
| 臺大學術典藏 |
2022-08-12T06:28:56Z |
Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence
|
Huang C.-S.; Chern H.-D.; Shen C.-Y.; Hsu S.-M.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:28:55Z |
Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility
|
Huang C.-S.; Chern H.-D.; KING-JEN CHANG; Cheng C.-W.; Hsu S.-M.; Shen C.-Y. |
| 臺大學術典藏 |
2022-08-12T06:28:54Z |
Ultrasound-guided mammotome biopsy of breast lesions in Taiwanese women
|
Lin J.-H.; Guo W.-H.; Huang C.-S.; KING-JEN CHANG; Shih J.-C.; Hsieh F.-J. |
| 臺大學術典藏 |
2022-08-12T06:28:53Z |
Utility assessment for different clinical phases of breast cancer in Taiwan
|
Chie W.-C.; Huang C.-S.; Chen J.-H.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:28:53Z |
Breast cancer screening in Taiwan and China
|
Huang C.-S.; KING-JEN CHANG; Shen C.-Y. |
| 臺大學術典藏 |
2022-08-12T06:28:25Z |
Prognostic factors for the survival of Taiwanese breast cancer patients
|
Chie W.-C.; Chang S.-H.; Huang C.-S.; Tzeng S.-J.; Chen J.-H.; Fan B.-Y.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-08-12T06:28:23Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; KING-JEN CHANG; Cheng A.-L. |
